“Latest Stem Cells News”

BioTime Inc.announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks. Derived from human embryonic stem cells but not fully differentiated into specific cell types, each ACTCellerate™ line provides a convenient, highly purified source of progenitor cells that may have applications in drug discovery, research, and the development of therapeutic products.

BioTime’s research products will soon be available to be ordered by researchers through Millipore’s stem cell homepage, www.millipore.com/stemcells. Millipore, which is already a leading supplier of stem cell research reagents, plans a full launch for BioTime’s progenitor cell lines and growth media during the first quarter of 2010.

Incoming search terms:

One of the most advanced research centers for the therapeutic applications of epithelial stem cells in the world, the ‘Stefano Ferrari’ regenerative medicine center at the University of Modena and Reggio Emilia, opened its doors with the ambitious goal of becoming the flagship research center in Italy. It was completely financed by the Modena Savings Bank, which invested 13 million euros for its completion and was inaugurated by Welfare Minister Maurizio Sacconi and Emilia-Romagna President Vasco Errani. It includes a new three floor, 30,000 square meter building (half of which is contamination controlled) at the University of Modena, and will employ 50 researchers and experts when fully operational.

Incoming search terms: